First Time Loading...

HUTCHMED (China) Ltd
LSE:HCM

Watchlist Manager
HUTCHMED (China) Ltd Logo
HUTCHMED (China) Ltd
LSE:HCM
Watchlist
Price: 324 GBX -3.86% Market Closed
Updated: May 19, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

1.3B
+26%
Assets
Growth Rates:
1 Year
+9%
3 Years
+147%
5 Years
+125%
7 Years
+302%
10 Years
+627%
515.5m
+23%
Liabilities
Growth Rates:
1 Year
+31%
3 Years
+181%
5 Years
+253%
7 Years
+257%
10 Years
+450%
782m
+28%
Equity
Growth Rates:
1 Year
-2%
3 Years
+129%
5 Years
+81%
7 Years
+338%
10 Years
+822%

Balance Sheet Decomposition
HUTCHMED (China) Ltd

1.3B
Assets
515.5m
Liabilities
1.3B
Assets
515.5m
Liabilities
Current Assets 1.1B
Cash & Short-Term Investments 857.4m
Receivables 167.2m
Other Current Assets 65.9m
Non-Current Assets 207m
Long-Term Investments 37.7m
PP&E 96.8m
Other Non-Current Assets 72.4m
Current Liabilities 340.9m
Accounts Payable 54.6m
Accrued Liabilities 213.4m
Other Current Liabilities 72.9m
Non-Current Liabilities 174.6m
Long-Term Debt 40.1m
Other Non-Current Liabilities 134.4m

Balance Sheet
HUTCHMED (China) Ltd

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
47
39
32
79
85
86
121
236
378
313
Cash
0
0
32
31
30
79
86
88
105
178
Cash Equivalents
47
39
0
48
55
7
35
148
273
135
Short-Term Investments
0
12
0
25
274
215
97
201
635
319
Total Receivables
15
36
46
49
59
57
79
67
149
129
Accounts Receivables
13
34
35
45
42
43
43
47
82
98
Other Receivables
2
2
11
4
16
14
36
20
67
31
Inventory
1
4
10
13
12
12
16
20
36
57
Other Current Assets
3
3
1
1
3
0
4
7
14
22
Total Current Assets
67
94
90
167
432
371
317
531
1 212
840
PP&E Net
7
9
10
11
15
18
27
32
53
85
PP&E Gross
7
9
10
11
15
18
27
32
53
85
Accumulated Depreciation
12
13
14
15
17
20
23
26
33
37
Intangible Assets
0
1
1
0
0
0
0
0
0
0
Goodwill
0
2
3
3
3
3
3
0
0
0
Note Receivable
0
0
0
0
0
0
16
0
0
0
Long-Term Investments
111
113
120
159
144
138
99
140
76
74
Other Long-Term Assets
0
0
7
2
2
2
2
22
31
31
Other Assets
0
2
3
3
3
3
3
0
0
0
Total Assets
186
N/A
219
+18%
230
+5%
342
+49%
598
+75%
532
-11%
465
-13%
724
+56%
1 373
+90%
1 029
-25%
Liabilities
Accounts Payable
4
20
24
36
24
26
24
32
41
71
Accrued Liabilities
8
7
21
27
33
48
74
111
194
246
Short-Term Debt
0
0
0
0
2
0
0
0
0
0
Current Portion of Long-Term Debt
52
26
23
20
30
0
3
3
27
0
Other Current Liabilities
14
15
13
12
16
11
12
13
50
37
Total Current Liabilities
78
69
81
95
105
85
113
158
312
354
Long-Term Debt
0
27
27
27
0
27
30
33
7
23
Deferred Income Tax
2
3
3
4
4
5
3
5
3
3
Minority Interest
16
25
19
20
23
23
25
35
53
27
Other Liabilities
0
0
16
12
4
3
6
9
12
13
Total Liabilities
97
N/A
124
+28%
146
+18%
158
+8%
136
-14%
143
+5%
177
+24%
240
+36%
386
+61%
419
+9%
Equity
Common Stock
52
53
57
61
66
67
67
73
86
86
Retained Earnings
69
66
92
80
107
183
290
416
610
971
Additional Paid In Capital
94
98
114
208
497
506
515
822
1 505
1 497
Other Equity
12
10
5
4
5
0
4
4
6
2
Total Equity
89
N/A
95
+7%
83
-12%
184
+121%
462
+151%
389
-16%
288
-26%
484
+68%
987
+104%
610
-38%
Total Liabilities & Equity
186
N/A
219
+18%
230
+5%
342
+49%
598
+75%
532
-11%
465
-13%
724
+56%
1 373
+90%
1 029
-25%
Shares Outstanding
Common Shares Outstanding
521
531
565
607
664
667
667
728
865
865

See Also

Summary
HCM intrinsic value, competitors valuation, and company profile.
DCF Valuation
HCM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HCM stock valuation using valuation multiples.
Wall Street Estimates
HCM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HCM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.